Live Skin Used to Heal Foot Wounds

FDA Advisory Panel Recommends Approval

Jan 7, 2000

On May 8, an advisory panel of the U.S. Food and Drug Administration (FDA) recommended approval of the bioengineered skin substitute Apligraf.

Manufactured by Organogenesis Inc., Apligraf is intended for use in the treatment of diabetic foot ulcers of greater than two weeks duration. Apligraf has already been given FDA clearance for the treatment of venous leg ulcers.

Foot Ulcers Can Lead to Amputation

Between 600,000 and 800,000 people in the United States currently suffer from diabetic foot ulcers. This foot complication is a potential cause of amputation and is the most frequent cause of hospitalization among people with diabetes. Diabetic foot ulcers are estimated to cost the U.S. health care system over $1 billion per year.

56 Percent of Diabetic Foot Ulcers Healed

The Apligraf diabetic ulcer pivotal trial was a large, prospective, randomized, multi-center study. For the study, 208 patients were treated with either Apligraf plus standard care or diabetic ulcer standard care alone.

Use of Apligraf healed 56 percent of ulcers within 12 weeks, compared to 38 percent healing with standard care alone. Use of Apligraf was also found to reduce time of healing. Complete healing was achieved in an average of 65 days with Apligraf, compared to 90 days with standard care alone.

Apligraf plus standard care was not associated with any significant side effects.

For more information, call Organogenesis 781-575-0775

Click Here To View Or Post Comments

Categories: Diabetes, Diabetes, Food, Foot Care, Government & Policy, Wound Care


Take the Diabetes Health Pump Survey
See What's Inside
Read this FREE issue now
For healthcare professionals only
  • What's on the Horizon with Diabetes Research and Therapy
See the entire table of contents here!

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter

Latest
Popular
Top Rated
Print | Email | Share | Comments (0)

You May Also Be Interested In...


Comments


Add your comments about this article below. You can add comments as a registered user or anonymously. If you choose to post anonymously your comments will be sent to our moderator for approval before they appear on this page. If you choose to post as a registered user your comments will appear instantly.

When voicing your views via the comment feature, please respect the Diabetes Health community by refraining from comments that could be considered offensive to other people. Diabetes Health reserves the right to remove comments when necessary to maintain the cordial voice of the diabetes community.

For your privacy and protection, we ask that you do not include personal details such as address or telephone number in any comments posted.

Don't have your Diabetes Health Username? Register now and add your comments to all our content.

Have Your Say...


Username: Password:
Comment:
©1991-2014 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.